Skip to main content
TipRanks
Go Ultimate75% OFF

Paul Clancy Insider Profile

4 Followers

Paul Clancy, Director at Incyte, holds 25.84K shares in Incyte (Ticker: INCY), holds 0.00 shares in Exact Sciences (Ticker: EXAS), holds 6.55K shares in Agios Pharma (Ticker: AGIO).

Paul Clancy's Trading History

INCY
Incyte
Oct 02, 2026DirectorUninformative Buy24.63K$3.13M
EXAS
Exact Sciences
Mar 23, 2026―Uninformative Sell―$0.00
AGIO
Agios Pharma
May 24, 2022DirectorUninformative Buy33.44K$206.88K
ALXN
Alexion Pharmaceuticals
Jul 15, 2019―Uninformative Sell649.57K$16.51M
BIIB
Biogen
Apr 27, 2017EVP & CFOUninformative Sell2.87M$7.75M
SION
Sionna Therapeutics, Inc.
―Director――
XLO
Xilio Therapeutics
―Director――

You May Also Like

Paul Clancy insider profile FAQ

What is the percentage of profitable transactions made by Paul Clancy?
The percentage of profitable transactions made by Paul Clancy is 33%.
What is the average return per transaction made by Paul Clancy?
The average return per transaction made by Paul Clancy is -7.80%.
What stocks does Paul Clancy hold?
Paul Clancy holds: INCY, ALXN, BIIB, EXAS, XLO, SION, AGIO stocks.
What was Paul Clancy’s latest transaction?
Paul Clancy’s latest transaction was an Uninformative Buy of $24.63K.
What was Paul Clancy's most profitable transaction?
Paul Clancy’s most profitable transaction was an Informative Sell of ALXN stock on July 12, 2018. The return on the trade was 10.00%.
What is Paul Clancy's role in Incyte?
Paul Clancy's role in Incyte is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.